MARKET REPORT: AstraZeneca shares sink on Chinese probe shock By Jon Hopkins Updated: 22:28 GMT, 30 October 2024 e-mail View comments AstraZeneca shares fell after it revealed the president of its business in China is under investigation by regulators in the People’s Republic. A spokesman for the FTSE 100 drugmaker said Leon Wang, who is also executive vice president of its international division, is co-operating with the probe by Chinese authorities. If requested, AstraZeneca added, it will fully co-operate with the investigation.
The firm said operations in the country are under the leadership of the general manager of AstraZeneca China. Probe: A spokesman for Astrazeneca said the president of its China business Leon Wang is co-operating with an investigation by Chinese authorities Last month, China detained five of AstraZeneca’s current and former employees, reportedly for questioning over possible infringement of data privacy laws and importing unlicensed medications. The drugs giant has been investing heavily in the country, announcing plans last year to build a £350million factory and recently signing a number of licensing deals with Chinese companies.
AstraZeneca shares slid 2.8 per cent, or 328p, to 11206p. Weakness in the pharma sector weighed on the FTSE 100 index, which closed down 0.
7 per cent, or 59.98 points, at 8159.63 while the FTSE 250 added 0.
4 per cent, or 71.33 points, to 20,694.12 as investors digested the Budget.
RELATED ARTICLES Previous 1 Next Stormy seas ahead for North Sea oil and gas as Chancellor...
Junior AIM index clocks up biggest one-day gain in four...
Next to unveil blockbuster £1bn profit as it defies the...
Private equity barons breathe a sigh of relief as Reeves is...
Share this article Share HOW THIS IS MONEY CAN HELP How to choose the best (and cheapest) stocks and shares Isa and the right DIY investing account Among those on the rise was Ladbrokes and Coral owner Entain (up 8.6 per cent, or 61.6p, to 774.
8p) amid relief that Chancellor Rachel Reeves did not launch the tax raid on gambling firms rumoured before the Budget. Stock Watch - Eckoh AIM is losing another firm to a takeover. Payment solutions provider Eckoh has accepted a bid from private equity firm Bridgepoint.
Eckoh has been considering the offer since August. The bid values the company at £169.3million, with the buyer offering 54p per share in cash.
That is an 11 per cent premium to Eckoh’s closing price before the deal was announced. Eckoh shares leapt 25 per cent, or 10.5p, to 52.
5p. Heading in the other direction, defence firm BAE Systems shed 0.8 per cent, or 10.
5p to 1269p in reaction to news of a major fire at its Barrow-in-Furness shipyard in Cumbria that builds Britain’s nuclear submarines. Miner Anglo American lost 3.9 per cent, or 97.
5p, to 2385.5p amid reports that former suitor BHP (down 1.3 per cent, or 29p, to 2181p) has moved on and intends to focus on other growth opportunities.
But mining peer Glencore added 1.2 per cent, or 5p to 409.6p following a mixed production performance for the first three quarters of the year, with copper, cobalt, zinc, and nickel output generally lower year-on-year, while steelmaking coal saw a significant increase.
Asia-focused lender Standard Chartered was a blue-chip gainer after results, gaining 4.1 per cent, or 36.2p, at 912.
6p as it upgraded its income guidance for the current financial year on the back of record quarterly growth from its Wealth Solutions and Global Markets segments. StanChart also said it hopes to return at least £6.1billion to shareholders between 2024 and 2026, representing an upgrade from previous guidance of at least £3.
85billion. Payment processor CAB Payments lost 5.2 per cent, or 6.
2p, at 114.2p as a weak third-quarter trading update countered news it is still in talks with US payments firm Stone X about a possible takeover. On AIM, financial services firm Equals Group found support from takeover hopes, rising 10.
7 per cent, or 12p, to 124p after revealing that it has received an improved proposal from an interested consortium. DIY INVESTING PLATFORMS AJ Bell AJ Bell Easy investing and ready-made portfolios Learn More Learn More Hargreaves Lansdown Hargreaves Lansdown Free fund dealing and investment ideas Learn More Learn More interactive investor interactive investor Flat-fee investing from £4.99 per month Learn More Learn More Saxo Saxo Get £200 back in trading fees Learn More Learn More Trading 212 Trading 212 Free dealing and no account fee Learn More Learn More Affiliate links: If you take out a product This is Money may earn a commission.
These deals are chosen by our editorial team, as we think they are worth highlighting. This does not affect our editorial independence. Compare the best investing account for you Share or comment on this article: MARKET REPORT: AstraZeneca shares sink on Chinese probe shock e-mail Add comment Some links in this article may be affiliate links.
If you click on them we may earn a small commission. That helps us fund This Is Money, and keep it free to use. We do not write articles to promote products.
We do not allow any commercial relationship to affect our editorial independence. More top stories.
Business
MARKET REPORT: AstraZeneca shares sink on Chinese probe shock
A spokesman said the president of its China business Leon Wang is co-operating with an investigation by Ch.inese authorities.